Parallel Session V: Outcomes

Cardiovascular Burden in Patients With ANCA-Associated and Non-ANCA Associated Vasculitis

Dr. Ana B Arevalo

@ANABELENAREVAL2

#Vasculitis22 Retrospective cohort study

AAV and non ANCA associated vasculitis compared

CV outcomes of interest.

#Vasculitis22

Parallel Session V: Outcomes

Outcomes in ANCA-Associated Vasculitis: Validating a Renal Risk Score and Examining the Impact of Deprivation

Dr. Dominic McGovern

@DomP_McGovern

#Vasculitis22 Large national cohort in Scotland

All renal biopsies in Scotland from 2014-2020 included.

EGPA and double positivity excluded.

#Vasculitis22

Parallel Session V: Outcomes

Malignancies in Patients with AAV Treated Within the EUVAS Trials

Dr. Beatriz Sánchez Álamo

#Vasculitis22 Future cancer risk is a concern with immunosuppression for AAV.

ncbi.nlm.nih.gov/pmc/articles/P…

#Vasculitis22

Parallel Session V: Outcomes

Neurologic Involvement in Anca-Associated Vasculitis: Data From Multicenter Longitudinal Observational Study

Prof. Rula Hajj-Ali

@RulaHajjAliMD

#Vasculitis22 Neurological involvement is common in AAV but has a variable presentation and not well studied.

#Vasculitis22

Parallel Session IV: Paediatric Vasculitis
Monogenic Mimics of Behçet’s Disease

Dr Alice Burleigh

@burleigh_alice

#Vasculitis22 More Monogenic Mimics of Behçet’s Disease have been reported recently but not thoroughly investigated

Aim and 1-slide method

#Vasculitis22

Parallel Session IV: Paediatric Vasculitis

Characteristics of Pediatric ANCA Associated Vasculitis Among Racial/Ethnic Minorities- single center experience from United States

Dr Deepika Singh
#Vasculitis22 The aim of this study was to study the characteristics of pediatric patients from racial/ethnic minorities with AAV

1-slide methods

#Vasculitis22

Parallel Session IV: Paediatric Vasculitis

Differentiating MIS-C from Kawasaki Disease, the second most common vasculitis of childhood

Prof. Seza Ozen

#Vasculitis22 Both have similar clinical manifestation and laboratory findings

This study aims to identify features to differentiate between the 2 diseases

Pictures of diagnostic criteria of both diseases

#Vasculitis22

Parallel Session IV: Paediatric Vasculitis

Outcomes of kidney transplantation in childhood-onset ANCA-associated vasculitis. A multicentre study

Dr Giorgio Trivioli

#Vasculitis22

1/6 Aim:
describe kidney transplantation outcomes among childhood-onset AAV

Inclusion criteria:
Diagnosis <18 yrs
Kidney transplant with at least 6 mo. follow-up

Exclusion criteria:
Kidney failure not due to AAV
Multi-organ transplant

21 centers
55 patients

#Vasculitis22

Parallel Session III: Proteomics and Metabolomics

Context and Future

Dr. Andreas Kronbichler

@AKronbichler How can we use biomarkers in vasculitis?

pubmed.ncbi.nlm.nih.gov/24257367/

#Vasculitis22

Parallel Session III: Proteomics and Metabolomics

Deconvolution of Transcriptomic Data Reveals Immune Cell Landscape of Inflammatory Infiltrates in Giant Cell Arteritis

Mr. Michal Zulcinski

#Vasculitis22 There are different patterns of inflammation in GCA.

#Vasculitis22

Parallel Session III: Proteomics and Metabolomics

RNA Sequencing of Leukocytes Reveals Unique Differences Among Groups of Adult Patients with IgA Vasculitis

Mr. Matija Bajzelj

#Vasculitis22 IgA vasculitis: an introduction

Biopsy gold standard for diagnosis.

#vasculitis22

Parallel Session III: Proteomics and Metabolomics

Biomarker and Clinical Data Linkage to Determine the Minimal mRNA Set for Vasculitis Diagnosis

Ms. Gisela Pattarone

#Vasculitis22 Aim was to discriminate healthy volunteers with active vasculitis, active versus remission and future flares using BIOPRED targeted mRNA.

#Vasculitis22

Parallel Session I: Epidemiology

Context and Future

Prof Neil Basu

#Vasculitis22 How can epidemiology be applied in vasculitis?

#Vasculitis22

Parallel Session I: Epidemiology

Characterisation of Systemic Vasculitis Outcomes Across a Nation: Do Different Models of Care Matter?

Dr. Rosemary Hollick

@RJ_Hollick

#Vasculitis22 How can we configure services to better serve patients with vasculitis?

This is the VOICES study.

abdn.ac.uk/iahs/research/…

#Vasculitis22

Parallel Session I: Epidemiology

Post-Induction ANCA Titer Does Not Predict Relapse, Mortality, or Renal Outcomes: A Target Trial Emulation Study

Dr. Zachary Wallace

@zach_wallace_md

#Vasculitis22 What is AAV?

What about ANCA titres?

Biomarkers key in AAV

#Vasculitis22

Parallel Session II: Translational Vasculitis

Clinical features and treatment of patients with severe skin changes in IgA vasculitis: multicenter study

Pediatric Rheumatology European Society: Vasculitis Working Group

Dr Marija Jelusic

#Vasculitis22 Aim:
- evaluate prevalence of severe skin manifestations
- propose treatment
- describe clinical course, laboratory findings, and outcome

#Vasculitis22

Parallel Session I: Epidemiology

Age and Time-Dependent Increase i Incident Anti-Glomerular Basement Membrane (Anti-GBM) Disease – A Nationwide Cohort Study

Dr. Karl Nelveg-Kristensen

#Vasculitis22 What do we know about anti GBM disease?

#Vasculitis22

Parallel Session II: Translational Vasculitis

Neutrophil mediated T-cell suppression in ANCA vasculitis and Covid-19

Dr Aisling Ui Mhaonaigh

#Vasculitis22 1-slide methods

#Vasculitis22

Parallel Session I: Epidemiology

FAIRVASC: A Semantic Web Approach to Rare Disease Registry Integration

Dr. Kris Mcglinn

#Vasculitis22 What are the challenges with rare disease data?

How can these be overcome?

#Vasculitis22

Parallel Session II: Translational Vasculitis

Pneumocystis jirovecii pneumonia (PJP) among incident cases of giant cell arteritis and polymyalgia rheumatica

Dr Michael Putman

#Vasculitis22 PJP is a common pathogen in immunocompromised patients but how does this affect patients with GCA or PMR who receive glucocorticoids?

1-slide methods

#Vasculitis22

Parallel Session I: Epidemiology

Negative Versus Positive Antineutrophil Cytoplasmic Antibody Granulomatosis with Polyangiitis: A Case-Control Study

Ms Marta Casal Moura

@martacasalmoura

#Vasculitis22 AAV represents a disease spectrum.

#Vasculitis22